Topical Rapamycin to Erase Angiofibromas in TSC
Public ClinicalTrials.gov record NCT01526356. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Study identification
- NCT ID
- NCT01526356
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Other
- Enrollment
- 179 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Rapamycin Drug
Drug
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2012
- Primary completion
- Jul 31, 2014
- Completion
- Jul 31, 2014
- Last update posted
- Oct 25, 2020
2012 – 2014
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| UCLA Mattel Children's Hospital | Los Angeles | California | 90095 | — |
| Jack & Julia Center for TSC at Oakland Children's Hospital & Research Center | Oakland | California | 94609 | — |
| Kennedy Krieger Institute | Baltimore | Maryland | 21205 | — |
| Herscot Center for Adults and Children with TSC Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Clinic Without Walls | Saint Paul | Minnesota | 55102-2697 | — |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | — |
| Texas Scottish Rite Hospital | Dallas | Texas | 75219 | — |
| The University of Texas Medical School at Houston | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01526356, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 25, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01526356 live on ClinicalTrials.gov.